| Developers: | US Medical Innovations (USMI) |
| Date of the premiere of the system: | September 2023 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Product Announcement
US Medical Innovations (USMI) has announced plans to showcase the artificial intelligence surgeon Canady next year. This was reported on September 22 by Mass Device.
The first screening of the system is planned at the First Global Cancer Surgical Summit in Jerusalem in January-February 2024.
Among the Canady tools are cold plasma and a three-dimensional non-contact biometric electromagnetic field. With their help, the robot releases and kills microscopic tumor cells during surgery without damage to non-cancer tissues.
 | This smart integrated system is the world's first therapy designed to remove mini tumors with surgical precision, Dr. Saravana Murphy, the company's vice president, said in a statement. |  |
In addition, the system has a mechanical arm and an electrosurgical generator that recognizes speech. The robot may be useful in laporoscopy, thoracoscopy, endoscopy, and mini-invasive surgical procedures.
| | The Canady system sets a new precedent in robotic oncology surgery, connecting AI technology and cold atmospheric plasma. This innovation sets a new standard, increasing accuracy and safety, "said Taisen Juang, chief technology officer. | |
USMI received approval on the use of the Canady Flex RoboWrist from the Food and Drug Administration in June 2023.
US Medical Innovations is a private health care company located in Maryland, United States. USMI aims to expand the boundaries of plasma medicine through the development of new technologies for the production of medical devices that improve the standard of living of people and help to cope with various diseases.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |